Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
New Patent expands patent estate covering Adial’s unique molecular genetic approach to…
New Patent expands patent estate covering Adial’s unique molecular genetic approach to…
Sign in to your account